Date: 27 Jan 2023
Time: 09:30 to 11.00
Location: Webinar

EIP national network event: Cannabis and Psychosis

EIP National network event on Cannabis and Psychosis. Prof Sir Robin Murray will speak on the impact of cannabis on the nature and incidence of psychosis, while Dr Marta Di Forti will speak on the treatment of cannabis induced psychosis.

Our guest speakers for the event:

  • Professor Sir Robin Murray, who will speak on the topic of “The impact of cannabis on the nature and incidence of psychosis”.

Robin Murray is Professor of Psychiatric Research at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. He is also Honorary Consultant Psychiatrist, South London and Maudsley NHS Foundation Trust. He was one of the first to suggest that schizophrenia was in part a neurodevelopmental disorder, and he has contributed to the understanding that environmental factors such as obstetric events, drug abuse and social adversity increase the risk of psychosis. He is the most frequently cited psychosis researcher outside the USA, has supervised 80 PhDs and 12 MD Theses, and over 50 of his students have become full professors. He was elected a Fellow of the Royal Society in 2010 and received a knighthood in 2011.

  • Dr Marta Di Forti, who will talk on “The treatment of cannabis-induced psychosis”.

Dr Marta Di Forti is a Clinical Reader in Psychosis Research at the Department of Social, Developmental and Genetic Research, Institute of Psychiatry, and Honorary Consultant Adult Psychiatrist, Lambeth EI Community team, South London and Maudsley NHS Foundation Trust. She leads the first cannabis clinic for patients with psychotic disorders in the UK. She was recently awarded the Royal College of Psychiatrist Researcher of the Year prize. In 2020 she was granted a MRC Senior Research Fellowship to expand her research in the role of cannabis use in psychosis and its underlying biology. With her team she showed for the first time that use of high potency types of cannabis e.g. "skunk" carries a higher risk of psychosis than use of traditional types and that it affects rates of psychotic disorders across Europe. Though it still remains unclear who are those cannabis users most at risk, her future work aims to investigate the interaction between cannabis use and genes predisposing to schizophrenia, and how cannabis changes the epigenome.

Sign up for the event here



This workshop will be recorded

This MS Teams event will be recorded to make it available to colleagues who could not attend.

The recording will be made available to all internal and external participants and other colleagues who expressed an interest and will be added to our website.

Please note that attendees do not appear on camera/audio during MS Teams live events. Text on the chat will not be captured in the recording.

On signing up for the webinar you provided personal details. We will use the data you provide to administer the event, including communicating with you about your attendance and evaluating the event.

We may also contact you about similar events in future.

For more information or to raise concerns about how Healthcare Improvement Scotland processes personal data, please see our main privacy notice:

or contact the HIS Data Officer via: